| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |